Le Lézard
Classified in: Health, Science and technology, Business
Subjects: LIC, JVN

Isabel Healthcare and Sigmoid Health Collaborate to Enhance Triage and Diagnostic Capabilities in SigmaMD Clinician


Isabel and Sigmoid collaboration aims to revolutionize diagnostic capabilities within the SigmaMD Clinician platform, empowering physicians with advanced tools to improve patient care and efficiency.

ANN ARBOR, Mich. and SANTA CLARA, Calif., Aug. 22, 2023 /PRNewswire-PRWeb/ -- Isabel Healthcare, a global leader in triage and diagnostic decision support, is thrilled to announce its partnership with Sigmoid Health, a leader in AI-powered healthcare management. This collaboration aims to revolutionize diagnostic capabilities within the SigmaMD Clinician platform, empowering physicians with advanced tools to improve patient care.

By combining our expertise in differential diagnosis intelligence with Sigmoid Health's AI-powered platform, we can enable physicians to make informed decisions and optimize patient care

The partnership between Isabel Healthcare and Sigmoid Health combines their expertise to enhance the diagnostic workflow for physicians. By integrating Isabel into SigmaMD Clinician, physicians gain access to a comprehensive set of possible conditions based on patient symptoms, complaints, and physician findings. The ranked differential diagnosis list is further prioritized by severity, enabling physicians to focus on the most critical potential causes. This streamlined workflow has the potential to reduce unnecessary emergency department admissions and facilitate timely treatment by primary care physicians.

"We are thrilled to partner with Isabel Healthcare," said Sid Bhatt, CEO of Sigmoid Health. "This integration aligns perfectly with our mission to develop AI-powered applications that enhance the physician-patient relationship and deliver improved healthcare outcomes. By leveraging Isabel's diagnostic expertise, we can provide physicians with enhanced diagnostic capabilities within the SigmaMD Clinician platform."

Donald H. Bauman, Jr., CEO of Isabel Healthcare USA, added, "We are excited to collaborate with Sigmoid Health to enhance diagnosis decision support within SigmaMD Clinician. By combining our expertise in differential diagnosis intelligence with Sigmoid Health's AI-powered platform, we can enable physicians to make informed decisions and optimize patient care."

In addition to the integration of Isabel into SigmaMD Clinician, the partnership aims to foster collaboration in the development of modern machine learning methods to further enhance diagnosis decision making capabilities and advance the field of healthcare diagnostics.

**About Isabel Healthcare**

Isabel Healthcare is a global leader in diagnostic decision support, providing clinicians with the tools and resources to assist in making accurate and timely diagnoses. The company's innovative solutions are used worldwide, enabling physicians to improve patient care and outcomes through enhanced diagnostic capabilities.

**About Sigmoid Health**

Sigmoid Health takes its name from the sigmoid function, a mathematical concept used in machine learning algorithms. The company's vision is to develop AI-powered applications that facilitate and enhance the physician-patient relationship, empowering patients to take a proactive role in their healthcare. Sigmoid Health is committed to providing access to affordable care, improving patient satisfaction, and demonstrating better outcomes.

Media Contact
Don Bauman, Isabel Healthcare, Inc., (734) 332-0612, [email protected], https://www.isabelhealthcare.com/
Sigmoid Health, Sigmoid Health, (956) 332-3030, [email protected], https://sigmoidhealth.com/

Twitter

SOURCE Isabel Healthcare, Inc.


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: